ArticleScience (New York, N.Y.)2024

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma.

Jaroslav Zak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.